Disparities in end-stage kidney disease care for children: a global survey
Rowena Lalji(The University of Queensland), David W. Johnson(Hennepin County), Vivekanand Jha(The George Institute for Global Health), Allison Tong(The University of Sydney), Armando Teixeira‐Pinto(The University of Sydney), John Feehally(University of Leicester), Germaine Wong(Children's Hospital at Westmead), Meaghan Lunney(University of Calgary), Anna Francis(Children's Health Queensland Hospital and Health Service), Andrea K. Viecelli(The University of Queensland), Feng Ye(University of Alberta), Mohamed A. Osman(University of Ottawa), David C.H. Harris(The University of Sydney), Aminu K. Bello(University of Alberta), Adeera Levin(University of British Columbia), Mignon McCulloch
Cited by 25
Related Papers
Worldwide access to treatment for end-stage kidney disease: a systematic review
|The Lancet|2015|2.3k
Chronic kidney disease and the global public health agenda: an international consensus
|Nature Reviews Nephrology|2024|1.1k
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886